Two Sigma Securities’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-47,100
Closed -$361K 2354
2019
Q2
$361K Buy
+47,100
New +$254K ﹤0.01% 1347
2018
Q4
Sell
-14,300
Closed -$246K 2671
2018
Q3
$246K Sell
14,300
-26,500
-65% -$394K ﹤0.01% 1922
2018
Q2
$569K Buy
40,800
+17,200
+73% +$290K ﹤0.01% 1673
2018
Q1
$362K Buy
+23,600
New +$337K ﹤0.01% 1875

Other funds holding PGEN

Two Sigma Securities's PGEN Position: Q2 2026 in Review

Two Sigma Securities sold out of Precigen (PGEN) in Q2 2026, closing a stake of 15,132 shares — an estimated $58.6K sold.

Two Sigma Securities first reported a position in PGEN in Q2 2017 and held it in 14 quarters. The position peaked at $374K in Q3 2025. 210 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Two Sigma Securities reported no remaining Precigen position as of Q2 2026 after selling out during the quarter.
  • Two Sigma Securities sold 15,132 Precigen shares in Q2 2026, an estimated $58.6K.
  • Two Sigma Securities first reported a position in Precigen in Q2 2017 and held it in 14 quarters.
  • Two Sigma Securities's Precigen position peaked at $374K in Q3 2025.
  • 210 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.